5 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we discuss the 5 best biotech stocks to buy according to Mark Lampert.
Merus N.v. (MRUS)
Get Email AlertsSector: Investment Advice
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,060,071 | $111,322 | 4.34% | |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,037,469 | $44,824 | 0.19% | |
| 3. | Commodore Capital Egen Atkinson And Michael Kramarz | 718,136 | $15,799 | 4.16% | |
| 4. | Driehaus Capital Richard Driehaus | 669,377 | $14,726 | -34% | 0.17% |
| 5. | Millennium Management Israel Englander | 556,523 | $12,244 | +74% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.75 | 26,894 | Large Shareholder | 462,015 | 2021-03-30 | Filing | |
| $19.75 | 108,106 | Large Shareholder | 2,892,385 | 2021-03-30 | Filing | |
| $19.75 | 165,000 | Large Shareholder | 3,803,152 | 2021-03-30 | Filing | |
| $22.75 | 7,744 | Large Shareholder | 435,121 | 2021-03-22 | Filing | |
| $22.75 | 71,756 | Large Shareholder | 3,638,152 | 2021-03-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.79 | 8,929 | Large Shareholder | 232,747 | 2021-10-08 | Filing | |
| $27.53 | 69,534 | Large Shareholder | 241,676 | 2021-10-07 | Filing | |
| $27.79 | 58,327 | Large Shareholder | 1,520,405 | 2021-10-08 | Filing | |
| $27.53 | 384,914 | Large Shareholder | 1,578,732 | 2021-10-07 | Filing | |
| $27.79 | 80,011 | Large Shareholder | 2,085,664 | 2021-10-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 33,200 | $1,056 | 0.11% | |
| 2. | 8,082 | $257 | 0% |
News See All
5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.
Where Do Hedge Funds Stand On Merus N.V. (MRUS)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Are Crazy About Merus N.V. (MRUS)
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31st...
Is MRUS A Good Stock To Buy Now?
With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth ...
Here is What Hedge Funds Think About Merus N.V. (MRUS)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Have Never Been This Bullish On Merus N.V. (MRUS)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Hedge Funds Have Never Been More Bullish On Merus N.V. (MRUS)
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
Is Merus N.V. (MRUS) Going to Burn These Hedge Funds?
Does Merus N.V. (NASDAQ:MRUS) represent a good buying opportunity at the moment? Let’s briefly check the hedge fund interest towards the company.
Baker Bros. Opened Positions In These 5 Healthcare Stocks
Julian Baker and Felix Baker founded Baker Bros. Advisors in 2000.
Billionaire Hedge Funds
